Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Low-glycemic Index Diet and ADHD. (GI-ADHD)

13. november 2026 opdateret af: Shimaa Shaker Attia Gafar, Kafrelsheikh University

Effect of Low Glycemic Index Diet in Attention Deficit Hyperactivity Disorder in Children.

This randomized controlled trial will evaluate the effect of a low glycemic index (GI) diet on symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents. A total of 128 participants aged 6 to ≤18 years, diagnosed with ADHD according to the Conners Parent Rating Scale-48 (CPRS-48), will be recruited from the pediatric neurology outpatient clinic at Kafrelsheikh University Hospital and randomly assigned in equal numbers (64 per group) to one of two arms. The intervention group will receive a structured low-GI diet (whole grains, legumes, low-GI non-starchy vegetables and fruits, and lean proteins, with refined flour, white rice, and sugary snacks limited) delivered through the Clinical Nutrition Unit, supported by a low-GI pyramid teaching tool, regular dietary counseling, and weekly dietitian review of 3-day food records to monitor adherence. The control group will continue a normal diet. ADHD symptoms will be assessed with the Conners 48 scale at baseline, 1 month, and 6 months. Children with other neurological conditions, autism spectrum disorder, intellectual disability, severe psychiatric conditions, chronic illnesses, diabetes, celiac disease, or food allergies requiring dietary restrictions will be excluded. Written informed consent will be obtained from parents or guardians, and the study has ethics committee approval (REC-KFSIRB200, Kafrelsheikh University).

Suggested additional fields

Primary outcome: Change in Conners 48 score from baseline to 1 and 6 months Study type / design: Interventional; parallel-group randomized controlled trial; prospective Intervention type: Dietary supplement/behavioral (dietary intervention)

Studieoversigt

Status

Ikke rekrutterer endnu

Intervention / Behandling

Detaljeret beskrivelse

Background and rationale

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder of childhood and adolescence, characterized by persistent inattention, hyperactivity, and impulsivity. It affects an estimated 3.4% of children and youth worldwide and places a considerable burden on the individual, family, and society, with consequences that include educational difficulties, strained peer relationships, accidental injuries, and substance misuse. Medication and behavioral therapy are the most effective established treatments, but diet is a modifiable environmental factor that has been explored as a complementary approach. The glycemic index (GI) ranks foods by their effect on blood glucose (low GI: under 55; medium: 55 to 70; high: above 70). It has been proposed that a low-GI diet, by providing a steady supply of glucose to the brain together with nutrients needed for neurotransmitter production, may stabilize blood glucose, improve cognitive performance, and reduce behavioral swings. No previous studies were identified that specifically examine the effect of a low-GI diet on ADHD in children, and clinical research is needed to confirm whether it is effective.

Objective

To explore the effect of a low-GI diet on ADHD symptoms in children and adolescents.

Study design

This is a prospective, interventional, parallel-group randomized controlled trial with two arms. The study will be conducted at the pediatric neurology outpatient clinic of Kafrelsheikh University Hospital, and the dietary intervention will be delivered at the outpatient clinic of the Clinical Nutrition Unit of the same hospital.

Sample size

No prior data were available, so a moderate effect size (Cohen's d = 0.5) was assumed. Using G*Power 3.1.9.7 for a two-tailed independent-samples t-test, with 80% power and a 5% significance level, the required sample size was 128 participants (64 per group).

Participants

128 children and adolescents aged 6 to 18 years with ADHD diagnosed using the Conners Parent Rating Scale-48 (CPRS-48).

Inclusion criteria:

Diagnosis of ADHD according to the Conners 48 scale Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion criteria:

Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children

Interventions

Group I (intervention, n = 64): Participants will follow a structured low-GI diet based on a Low-GI Pyramid used as a teaching tool. The diet emphasizes whole grains (e.g., oats, barley), legumes (e.g., lentils, beans), non-starchy vegetables and fruits with a GI below 55, and lean proteins, while limiting high-GI foods such as refined flour, white rice, and sugary snacks. Compliance will be monitored through weekly dietitian review of 3-day food records. Regular dietary counseling sessions with parents will reinforce adherence and resolve problems as they arise.

Group II (control, n = 64): Participants will continue their normal diet.

Assessments

All participants will undergo:

Complete history taking (presenting symptoms, onset, duration, impact across settings, family, developmental, medical, and school history) Complete systemic clinical examination (heart, chest, abdomen, and general examination) Comprehensive nutritional assessment, including dietary history, anthropometric measurements (weight, height, BMI, and their Z-scores), and a nutrition-focused physical examination to rule out signs of micronutrient deficiency ADHD symptom assessment using the Conners Parent Rating Scale-48 at baseline, 1 month, and 6 months

Outcome measures

The primary outcome is the change in Conners 48 score from baseline to 1 month and 6 months, compared between the low-GI diet group and the control group. Dietary adherence, based on 3-day food records, is monitored throughout.

Statistical analysis

Data will be analyzed with statistical software using appropriate methods and presented in tables and graphs.

Ethics

The study has been approved by the Scientific Research Ethics Committee, Kafrelsheikh University (REC-KFSIRB200). Written informed consent will be obtained from the parents or guardians of each child before data collection begins.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

128

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

6 år til 18 år (Barn, Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Diagnosis of ADHD according to the Conners Parent Rating Scale-48 (CPRS-48) Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion Criteria:

  • Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Low glycemic index diet.

Children and adolescents with ADHD (n = 64) follow a structured low-GI diet based on a Low-GI Pyramid teaching tool: whole grains, legumes, low-GI non-starchy vegetables and fruits (GI below 55), and lean proteins, limiting refined flour, white rice, and sugary snacks. Regular dietary counseling sessions and weekly dietitian review of 3-day food records support adherence.

Structured low-GI diet with dietary counseling and weekly review of 3-day food records.

Linked arm: Arm 1

Ingen indgriben: Normal diet (control).

Children and adolescents with ADHD (n = 64) continue their usual diet.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in ADHD symptom severity.
Tidsramme: Baseline, 1 month, and 6 months.

Change in total score on the Conners Parent Rating Scale-48 (CPRS-48), completed by parents or caregivers. The change from baseline is compared between the low glycemic index diet group and the normal diet group. Higher scores indicate more severe symptoms.

Baseline, 1 month, and 6 months.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

30. november 2026

Primær færdiggørelse (Anslået)

30. juni 2027

Studieafslutning (Anslået)

31. juli 2027

Datoer for studieregistrering

Først indsendt

13. november 2026

Først indsendt, der opfyldte QC-kriterier

13. november 2026

Først opslået (Faktiske)

19. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

19. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner